ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 192 filers reported holding ARGENX SE in Q1 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $418,429 | +12.5% | 973 | +3.0% | 0.02% | +14.3% |
| Q1 2024 | $372,065 | -9.2% | 945 | -12.3% | 0.01% | -22.2% |
| Q4 2023 | $409,723 | -8.1% | 1,077 | +18.7% | 0.02% | -28.0% |
| Q3 2023 | $445,908 | +19.1% | 907 | -5.6% | 0.02% | +25.0% |
| Q2 2023 | $374,531 | -12.2% | 961 | -16.1% | 0.02% | -23.1% |
| Q1 2023 | $426,604 | +6.5% | 1,145 | +8.3% | 0.03% | 0.0% |
| Q4 2022 | $400,423 | -44.6% | 1,057 | -48.4% | 0.03% | -50.0% |
| Q3 2022 | $723,000 | -16.2% | 2,049 | -10.1% | 0.05% | -5.5% |
| Q2 2022 | $863,000 | +3.6% | 2,279 | -13.7% | 0.06% | +57.1% |
| Q1 2022 | $833,000 | +85.1% | 2,641 | +105.4% | 0.04% | +133.3% |
| Q4 2021 | $450,000 | +43.3% | 1,286 | +23.5% | 0.02% | +36.4% |
| Q3 2021 | $314,000 | +4.7% | 1,041 | +4.4% | 0.01% | +10.0% |
| Q2 2021 | $300,000 | +12.4% | 997 | +2.7% | 0.01% | 0.0% |
| Q1 2021 | $267,000 | -2.9% | 971 | +3.7% | 0.01% | -16.7% |
| Q4 2020 | $275,000 | – | 936 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 78,138 | $12,543,000 | 7.60% |
| Redmile Group, LLC | 1,153,232 | $185,117,000 | 4.43% |
| Avoro Capital Advisors LLC | 936,500 | $150,327,000 | 4.41% |
| MPM BioImpact LLC | 71,700 | $11,509,000 | 4.08% |
| AWM Investment Company, Inc. | 95,000 | $15,249,000 | 2.98% |
| EcoR1 Capital, LLC | 202,117 | $32,444,000 | 2.92% |
| INDUS CAPITAL PARTNERS, LLC | 79,095 | $12,696,000 | 2.49% |
| Bellevue Group AG | 967,989 | $156,070,000 | 2.47% |
| DCF Advisers, LLC | 22,000 | $3,531,000 | 2.24% |
| Dorsey Wright & Associates | 41,416 | $6,648,000 | 2.20% |